Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis

H Mandel1, N Abeling, A Gutman

  • 1Department of Pediatrics, Rambam Medical Center, Technion Faculty of Medicine, Haifa, Israel. h_mandel@rambam.health.gov.il

Prenatal Diagnosis
|December 13, 2000
PubMed

Insights

Prenatal diagnosis of prolidase deficiency is feasible, but clinical severity varies greatly. This case highlights challenges in genetic counseling for families with this rare genetic disorder.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Pediatrics

Background:

  • Prolidase deficiency is an autosomal recessive condition with highly variable clinical presentations.
  • Clinical severity ranges from asymptomatic to fatal, complicating prognosis and management.
  • Genetic counseling for prolidase deficiency presents challenges due to unpredictable disease course.

Observation:

  • This study reports the first prenatal diagnosis of prolidase deficiency in a family with a previously severely affected child.
  • The parents pursued a second pregnancy, resulting in a healthy-appearing infant.
  • Despite prenatal diagnosis, the infant was confirmed to have severe prolidase deficiency postnatally.

Findings:

  • The infant, diagnosed with severe prolidase deficiency, remained asymptomatic at 4 months of age.
  • This contrasts with the family's first child who exhibited severe symptoms from birth.
  • Prenatal diagnosis confirmed the condition, but the infant's asymptomatic state was unexpected.

Implications:

  • The feasibility of prenatal diagnosis for prolidase deficiency is established.
  • The unpredictable clinical variability underscores the difficulties in genetic counseling.
  • Further research is needed to understand the factors influencing prolidase deficiency severity.